Table 1.

Mean weights and serum glucose for each group

	Weight, g				Glucose, mg/dl
Group	10 wk	16 wk	20 wk	34 wk	10 wk	16 wk	20 wk	34 wk
SA	319 ± 9.2	426 ± 5.5	488 ± 7.9	566 ± 9.8	170 ± 18	173 ± 16	175 ± 15	158 ± 5.5
SB	317 ± 9.2	426 ± 6.8	487 ± 6.1	577 ± 4.2	166 ± 8.1	161 ± 9.7	180 ± 5.9	154 ± 3.2
IA	321 ± 9.5	426 ± 10	479 ± 11	552 ± 17	174 ± 8.8	175 ± 9.0	173 ± 14	150 ± 6.2
IB	311 ± 9.9	427 ± 11	481 ± 11	584 ± 28	174 ± 9.4	169 ± 16	182 ± 10	155 ± 5.1
Lean	314 ± 34	414 ± 10	478 ± 16	530 ± 12	122 ± 7.6	137 ± 5.2	124 ± 3.2	137 ± 1.3

Rats were divided into the following groups: rats subjected to sham operation and that received control, serum amyloid A (SAA)-negative tubular cells (SA group), rats subjected to sham operation and that received SAA-expressing tubular cells (SB group), rats subjected to renal ischemia and that received control, SAA-negative tubular cells (IA group), and rats subjected to renal ischemia and that received SAA-expressing tubular cells (IB group). Lean rats were lean, age-matched male Zucker/SHHF F₁ hybrid rats. Mean blood glucose in the diabetic groups (SA, SB, IA, and IB groups) was significantly greater than in lean animals at each time point.